Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Protection certificate |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 12 2013 000 017.1 |
| Use | VZ | Medicinal products |
95 | Product name | TIEZ | Teduglutid in allen dem Schutz des Grundpatents unterliegenden Formen |
54 | Title of basic patent | TIGZ | ANALOGE DES GLUCAGON ÄHNLICHEN PEPTIDES -2 |
51 | IPC main class | ICM (ICMV) | C07K 14/605 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 38/26 (2006.01), G01N 33/68 (2006.01) |
94 | Start of term of protection | LB | Apr 12, 2017 |
94 | End of term of protection | LE | Apr 11, 2022 |
22 | DE application date | DAT | Feb 25, 2013 |
| Date of publication of application for a certificate | OT | May 8, 2013 |
| Date of publication of grant of certificate | PET | Oct 22, 2015 |
71/73 | Applicant/owner | INH | 1149336 Ontario, Inc., 19 Fernwood Road, Toronto, CA; Shire-NPS Pharmaceuticals, Inc. (n. d. Ges. d. Staates Delaware), 300 Shire Way, 02421 Lexington, US |
74 | Representative | VTR | Maiwald GmbH, 80335 München, DE |
| Address for service | | Maiwald GmbH, 80065 München, DE |
| Patent division in charge | | 44 |
68 | DE file number of basic patent | GAKZ | 697 16 905.7 |
68 | EP file number of basic patent | GEAKZ | 97 91 6280.7 |
43 | Date of first publication | EVT | May 8, 2013 |
92 92 92
| Domestic authorisation | GIS GIN GIT
| Europäische Kommission EU 1/12/787/001 2012-08-30
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| Europäische Kommission EU EU1/12/787/001 2012-08-30
|
| Date of the first transfer into DPMAregister | EREGT | May 8, 2013 |
| Date of the (most recent) update in DPMAregister | REGT | Aug 9, 2024 (Show all update days)(Hide all update days)- Aug 9, 2024
- Representative: changed
- Address for service: changed
- Apr 30, 2022; Apr 13, 2022; Jan 25, 2022; Mar 31, 2021; Mar 26, 2020; Jul 16, 2019; Mar 28, 2019; Oct 5, 2018; May 10, 2018; May 8, 2018; Apr 13, 2018; May 24, 2017; May 9, 2017; Oct 22, 2015; Sep 16, 2015; Jul 11, 2015; Jul 7, 2015; Jul 3, 2015; Jul 5, 2014; May 3, 2014; Mar 1, 2014; Oct 3, 2013; Sep 24, 2013; Jul 25, 2013
- Historical data not available for this/these date(s)
- May 8, 2013
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 3)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Mar 27, 2013 |
71/73 | Applicant/owner | INH | 1149336 Ontario, Inc., Toronto, CA; NPS Pharmaceuticals,Inc., 07921 Bedminster, N.J., US |
71/73 | Previous applicant/owner | INHF | 1149336 Ontario, Inc., Toronto, CA |
View procedures New applicant/owner details (No.: 6)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | May 23, 2017 |
71/73 | Applicant/owner | INH | 1149336 Ontario, Inc., Toronto, CA; Shire-NPS Pharmaceuticals, Inc. (n. d. Ges. d. Staates Delaware), 07921 Bedminster, N.J., US |
71/73 | Previous applicant/owner | INHF | 1149336 Ontario, Inc., Toronto, CA, NPS Pharmaceuticals,Inc., 07921 Bedminster, N.J., US |
View procedures New applicant/owner details (No.: 7)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Oct 4, 2018 |
71/73 | Applicant/owner | INH | 1149336 Ontario, Inc., Toronto, CA; Shire-NPS Pharmaceuticals, Inc. (n. d. Ges. d. Staates Delaware), 02421 Lexington, US |
71/73 | Previous applicant/owner | INHF | 1149336 Ontario, Inc., Toronto, CA, Shire-NPS Pharmaceuticals, Inc. (n. d. Ges. d. Staates Delaware), 07921 Bedminster, N.J., US |